OICHARTS
8 AMThe 8 AM report →
PharmaMedium impactAfter close

Mankind Pharma acquires Rivotril brand from Roche

after close1 source ↓written by the desknot a recommendation

Mankind Pharma has acquired the Rivotril brand from Roche, gaining exclusive rights to manufacture and distribute the product in India. Rivotril, a leading treatment for neurological and psychiatric conditions, enhances Mankind's position in the CNS therapy segment. This move aligns with the company's strategy to expand its chronic therapies portfolio, which is increasingly contributing to overall business growth.

Not investment advice. For informational purposes only.

OI Charts is not a SEBI-registered investment adviser or research analyst. This bulletin was written by the OI Charts desk from the public sources listed here. It is commentary on market conditions, not a basis for any investment decision and not a recommendation to buy or sell any security. Prices as of 18 Mar 2026, 16:04 IST.

Sourcesnews.google.com

Read inENहिंతెमराதગુ

The market after the news

MANKIND closed −4.9% on the day of the news, from ₹2,103.10 to ₹2,000.80; Nifty −3.3% over the same session; futures OI +2.9%.

Bulletin at 16:04 IST on 18 Mar 2026. Every change is measured from ₹2,103.10, the last close before it, on 18 Mar. Nifty 50 is measured over the same sessions.

  • MANKIND close ₹
  • Nifty 50, rebased to the close before the news
  • close before the news
  • above it
  • below it
  • futures OI, lots
MANKIND closes around the bulletin against the close before the news, with Nifty 50 rebased to it187621032330axis spans 24%before the news · 18 Mar2103Nifty 50MANKINDbulletinD0+1+3+512 Mar24 Mar7 AprFutures open interest, lotspeak 14,000Reference close ₹2,103.10. 16 sessions from 12 Mar to 7 Apr; the price axis spans 24 percent.
price axis fixed at 4 × the 14-session true range around the close before the news · values printed at each marked session
Closes after the news against the close before it, with Nifty 50 over the same span
SessionClose ₹Change %Nifty %
Before18 Mar₹2,103.10basebase
On the day19 Mar₹2,000.80▼ −4.9%▼ −3.3%−1.6 pp difference
+1 session20 Mar₹2,000.00▼ −4.9%▼ −2.8%−2.1 pp difference
+3 sessions24 Mar₹1,987.80▼ −5.5%▼ −3.6%−1.8 pp difference
+5 sessions27 Mar₹2,038.80▼ −3.1%▼ −4.0%+1.0 pp difference
Gap at the open, % · ₹
▼ −0.3%−5.68 on 19 Mar
Day's range, % · ₹
4.9%≈ 100 high to low
Volume on the day
1.35×the 20-session average
Futures OI on the day
▲ +2.9%+360 lots · short build-up · price −4.9%
Futures OI open, lots
13,00019 Mar · 30 Mar expiry
Futures premium, ₹
+6.20+0.3% to spot
Puts per call, by OI
0.37from 0.39 the session before
Max pain
2,140from 2,180 the session before

Source NSE UDiFF bhavcopy · MANKIND on the desk →

Thread · MANKINDAll MANKIND bulletins →

Related